| 摘要 |
FIELD: pharmaceutics. SUBSTANCE: the present innovation deals with aqueous pharmaceutical compositions of erythropoietin being free of human serum products, stabilized with amino acid and derivatives of sorbitan mono-9-octadecenoate poly(oxy- 1.2-ethandiyl). The present innovation, also, deals with aqueous stable pharmaceutical erythropoietin compositions containing conservants that contain antibacterial quantities of cresol and amino acid. Pharmaceutical compositions are stable and free of human blood products, such as albumin. EFFECT: higher efficiency. 52 cl, 4 dwg, 7 tbl |
